Hølmkjær, Pernille
Vermehren, Charlotte
Holm, Anne
Rozing, Maarten Pieter
Høj, Kirsten
Overbeck, Gritt
Funding for this research was provided by:
The Velux Foundation l (00025829, 00025829, 00025829, 00025829)
Article History
Received: 26 April 2022
Accepted: 12 December 2022
First Online: 26 December 2022
Declarations
:
: The study was conducted in compliance with the Helsinki Declaration in its latest form, good clinical practice guidelines, and followed the rules for informed consent. According to Danish legislation and defined in “Danish Act on Research Ethics Review of Health Research Projects, Sect. 2” this trial constitutes a qualitative improvement study and does not directly interfere with patients concerning novel treatments, which does not require external monitoring nor ethical approval according to the Committee Act, Sect. 1, subsection 4. The Regional Ethical Committee was informed about the trial and waivered ethical approval according to the mentioned legislation [CitationRef removed, CitationRef removed] (Journal no: H-20084023).
: Not applicable.
: The authors declare that they have no competing interests.